Peripheral thyroid dysfunction in depression

World Journal of Biological Psychiatry

Volumn 7, Issue 3, 2006, Pages 131-137

  Fountoulakis, Konstantinos ^a   Kantartzis, Sotiris ^a   Siamouli, Melina ^a   Panagiotidis, Panagiotis ^a   Kaprinis, Stergios ^a   Iacovides, Apostolos ^a   Kaprinis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Depression; Psychoneuroendocrinology; Thyroid function

Indexed keywords

ANTIDEPRESSANT AGENT; LIOTHYRONINE; PAROXETINE; PLACEBO; SERTRALINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

AUTOIMMUNITY; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FREE THYROXINE INDEX; GESTATION PERIOD; HASHIMOTO DISEASE; HOSPITAL PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LONGITUDINAL STUDY; MAJOR DEPRESSION; MEDICAL DOCUMENTATION; PROGNOSIS; PUERPERIUM; RARE DISEASE; REVIEW; SCREENING TEST; THYROID DISEASE; THYROID FUNCTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; THYROID FUNCTION TESTS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TRIIODOTHYRONINE;

EID: 33746494118     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970500474739     Document Type: Review

References (102)

1. Agid, O and Lerer, B. (2003) Algorithm-based treatment of major depression in an outpatient clinic: Clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation Int J Neuropsychopharmacol, 6, pp. 41-49.
2. Altshuler, LL and Frye, MA and Gitlin, MJ. (2003) Acceleration and augmentation strategies for treating bipolar depression Biol Psychiatry, 53, pp. 691-700.
3. Banki, C and Vojnik, M and Arato, M and Papp, Z and Kovacs, Z. (1985) Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders Eur Arch Psychiatry Neurol Sci, 235, pp. 32-37.
4. Bauer, M and Baur, H and Berghofer, A and Strohle, A and Hellweg, R and Muller-Oerlinghausen, B and Baumgartner, A. (2002) Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders J Affect Disord, 68, pp. 285-94.
5. Bauer, M and Whybrow, P and Winokur, A. (1990) Rapid cycling bipolar affective disorder I: Association with grade I hypothyroidism Arch Gen Psychiatry, 47, pp. 427-432.
6. Bauer, M. (2002) Thyroid hormone augmentation with levothyroxine in bipolar depression Bipolar Disord, 4(Suppl 1), pp. 109-110.
7. Berlin, I and Payan, C and Corruble, E and Puech, A. (1999) Serum thyroid-stimulating-hormone concentration as an index of severity of major depression Int J Neuropsychopharmcol, 2, pp. 105-110.
8. Bermudez, F and Surks, M and Oppenheimer, J. (1975) High incidence of decreased serum triiodothyroine concentration in patients with non-thyroidal disease J Clin Endocrinol Metab, 41, pp. 27-31.
9. Broe, G and Henderson, A and Creasey, H and McCusker, E and Korten, A and Jorm, A and Longley, W and Anthony, J. (1990) A case control study of Alzheimer's disease in Austria Neurology, 40, pp. 1698-1707.
10. Bunevicius, R and Kazanavicius, G and Telksnys, A. (1994) Thyrotropin response to TRH stimulation in depressed patients with autoimmune thyroiditis Biol Psychiatry, 36, pp. 543-547.
11. Burch, H.(1995) Abnormal thyroid function test results in euthyroid persons. In Principles and practice of endocrinology and metabolism. (pp. 323-332). Philadelphia PA: JB Lippincott Company.
12. Cadieux, RJ. (1998) Practical management of treatment-resistant depression Am Fam Phys, 58, pp. 2059-2062.
13. Carta, M and Hardoy, M and Boi, M and Mariotti, S and Carpiniello, B and Usai, P. (2002) Association between panic disorder, major depressive disorder and celiac disease: A possible role of thyroid autoimmunity J Psychosom Res, 53, pp. 789-793.
14. Carta, M and Hardoy, M and Usai, P and Carpiniello, B and Angst, J. (2003) Recurrent brief depression in celiac disease J Psychosom Res, 55, pp. 573-574.
15. Cole, D and Thase, M and Mallinger, A and Soares, J and Luther, J and Kupfer, D and Frank, E. (2002) Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function Am J Psychiatry, 159, pp. 116-121.
16. Custro, N and Scafidi, V and LoBaido, R and Nastri, L and Abbate, G and Cuffaro, M and Gallo, S and Vienna, G and Notarbartolo, A. (1994) Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression J Endocrinol Invest, 17, pp. 641-646.
17. Dally, P and Rohde, P. (1961) Comparison of antidepressant drugs in depressive illnesses Lancet, i, pp. 18-20.
18. David, M and Owen, J and Abraham, G and Delva, N and Southmayd, S and Wooltorton, E and Lawson, J. (2000) Thyroid function and response to 48-hour sleep deprivation in treatment-resistant depressed patients Biol Psychiatry, 48, pp. 323-326.
19. DeMendoncaLima, C and Vandel, S and Bonin, B and Bertschy, G and Bizouard, P. (1996) Thyroid function in depressed patients Encephale, 22, pp. 85-94.
20. Dording, CM. (2000) Antidepressant augmentation and combinations Psychiatr Clin North Am, 23, pp. 743-55.
21. Duval, F and Mokrani, M and Bailey, P and Correa, H and Diep, T and Crocq, M and Macher, J. (1999) Thyroid axis activity and serotonin function in major depressive episode Psychoneuroendocrinology, 24, pp. 695-712.
22. Elenkov, I and Chrousos, G. (2002) Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity Ann NY Acad Sci, 966, pp. 290-303.
23. Evans, D and Golden, R.(1987) The dexamethasone suppression test: A review. In Handbook of clinical psychoneuroendocrinology. (pp. 313-335). New York: John Wiley and Sons.
24. Fava, M. (2000) New approaches to the treatment of refractory depression J Clin Psychiatry, 61(Suppl 1), pp. 26-32.
25. Fava, M and Labbate, L and Abraham, M and Rosenbaum, J. (1995) Hypothyroidism and hyperthyroidism in major depression revisited J Clin Psychiatry, 56, pp. 186-192.
26. Fountoulakis, K and Fotiou, F and Iacovides, A and Karamouzis, M and Goulas, A and Demetriadou, A and Kaprinis, G. (2001) Relationship between pupillometric findings, DST and melancholia Acta Psychiatr Belg, 101, pp. 202-235.
27. Fountoulakis, K and Iacovides, A and Grammaticos, P and Kaprinis, G and Bech, P. (2004) Thyroid function and clinical subtypes of major depression: An exploratory study BMC Psychiatry, 4, pp. 6.
28. Fountoulakis, K and Iacovides, A and Nimatoudis, I and Kaprinis, G and Ierodiakonou, C. (1999) Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression Eur Psychiatry, 14, pp. 426-434.
29. Frye, M and Dunn, R and Gary, K and Kimbrell, T and Callahan, A and Luckenbaugh, D and Cora-Locatelli, G and Vanderham, E and Winokur, A and Post, R. (1999) Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression Biol Psychiatry, 45, pp. 1049-1052.
30. Gewirtz, G and Malaspina, D and Hatterer, J and Feureisen, S and Klein, D and Gorman, J. (1988) Occult thyroid dysfunction in patients with refractory depression Am J Psychiatry, 145, pp. 1012-1014.
31. Gold, M and Pottash, A and Extein, I. (1982) Symptomless autoimmune thyroiditis in depression Psychiatry Res, 6, pp. 261-269.
32. Haggerty, J and Evans, D and Golden, R and Pedersen, C and Simon, J and Nemeroff, C. (1990) The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders Biol Psychiatry, 27, pp. 51-60.
33. Haggerty, J and Stern, R and Mason, G and Beckwith, J and Morey, C and Prange, A. (1993) Subclinical hypothyroidism: A modifiable risk factor for depression? Am J Psychiatry, 150, pp. 508-510.
34. Haggerty, J and Silva, S and Marquardt, M and Mason, G and Chang, H and Evans, D and Golden, R and Pedersen, C. (1997) Prevalence of antithyroid antibodies in mood disorders Depression Anxiety, 5, pp. 91-96.
35. Harris, B. (1999) Postpartum depression and thyroid antibody status Thyroid, 9, pp. 699-703.
36. Harris, B and Fung, H and Johns, S and Kologlu, M and Bhatti, R and McGregor, A and Richards, C and Hall, R. (1989) Transient post-partum thyroid dysfunction and postnatal depression J Affect Disord, 17, pp. 243-249.
37. Harris, B and Othman, S and Davies, J and Weppner, G and Richards, C and Newcombe, R and Lazarus, J and Parkes, A and Hall, R and Phillips, D. (1992) Association between postpartum thyroid dysfunction and thyroid antibodies and depression Br Med J (Clin Res Edn), 305, pp. 152-156.
38. Harris, B and Oretti, R and Lazarus, J and Parkes, A and John, R and Richards, C and Newcombe, R and Hall, R. (2002) Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women Br J Psychiatry, 180, pp. 327-330.
39. Heyman, A and Wilkinson, W and Stafford, J. (1984) Alzheimer's disease: A study of epidemiological aspects Ann Neurol, 15, pp. 335-341.
40. Howland, R. (1993) Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment J Clin Psychiatry, 54, pp. 47-54.
41. Iacovides, A and Fountoulakis, K and Grammaticos, P and Ierodiakonou, C. (2000) Difference in symptom profile between generalized anxiety disorder and anxiety secondary to hyperthyroidism Int J Psychiatry Med, 30, pp. 71-81.
42. Jackson, I. (1998) The thyroid axis and depression Thyroid, 8, pp. 951-956.
43. Jankovic, BD. (1985) Neural tissue hypersensitivity in psychiatric disorders with immunologic features J Immunol, 135, pp. 853-857s.
44. Joffe, R. (1987) Antithyroid antibodies in major depression Acta Psychiatr Scand, 76, pp. 598-599.
45. Joffe, R. (1999) Peripheral thyroid hormone levels in treatment resistant depression Biol Psychiatry, 45, pp. 1053-1055.
46. Joffe, R and Marriott, M. (2000) Thyroid hormone levels and recurrence of major depression Am J Psychiatry, 157, pp. 1689-1691.
47. Joffe, R and Bagby, R and Levitt, A. (1992) The thyroid and melancholia Psychiatry Res, 42, pp. 73-80.
48. Joffe, R and Segal, Z and Singer, W. (1996) Change in thyroid hormone levels following response to cognitive therapy for major depression Am J Psychiatry, 153, pp. 411-413.
49. Joffe, RT. (1997) Refractory depression: Treatment strategies, with particular reference to the thyroid axis J Psychiatry Neurosci, 22, pp. 327-331.
50. JoffeRT. 1998. The use of thyroid supplements to augment antidepressant medication. J Clin Psychiatry 59(Suppl 5):26-29; Discussion 30-31.
51. Joffe, RT and Sokolov, ST. (1994) Thyroid hormones, the brain, and affective disorders Crit Rev Neurobiol, 8, pp. 45-63.
52. Joffe, RT and Sokolov, ST. (2000) Thyroid hormone treatment of primary unipolar depression: A review Int J Neuropsychopharmacol, 3, pp. 143-147.
53. Kaptein, E. (1993) Clinical application of free thyroxine determinations Clin Lab Med, 13, pp. 653-672.
54. Kent, G and Stuckey, B and Allen, J and Lambert, T and Gee, V. (1999) Postpartum thyroid dysfunction: Clinical assessment and relationship to psychiatric affective morbidity Clin Endocrinol, 51, pp. 429-438.
55. Kjellman, B and Ljunggren, J and Beck-Friis, J and Wetterberg, L. (1985) Effect of TRH on TSH and prolactin levels in affective disorders Psychiatry Res, 14, pp. 353-363.
56. Kocsis, J and Davis, J and Katz, M and Koslow, S and Stokes, P and Casper, R and Redmond, D. (1985) Depressive behavior and hyperactive adrenocortical function Am J Psychiatry, 142, pp. 1291-1298.
57. Kokmen, E and Beard, R and Chandra, V and Offord, K and Schoenberg, B and Ballard, D. (1991) Clinical risk factors for Alzheimer's disease: A population-based case-control study Neurology, 41, pp. 1393-1397.
58. Konig, F and Hauger, B and vonHippel, C and Wolfersdorf, M and Kaschka, W. (2000) Effect of paroxetine on thyroid hormone levels in severely depressed patients Neuropsychobiology, 42, pp. 135-138.
59. Kuijpens, J and Vader, H and Drexhage, H and Wiersinga, W and van Son, M and Pop, V. (2001) Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum Eur J Endocrinol, 145, pp. 579-584.
60. Leentjens, AF and Kappers, EJ. (1995) Persistent cognitive defects after corrected hypothyroidism Psychopathology, 28, pp. 235-237.
61. Legros, S and Mendlewicz, J and Wybran, J. (1985) Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders Eur Arch Psychiatry Neurol Sci, 265, pp. 9-11.
62. Liebowitz, M and Quitkin, F and Stewart, J and McGrath, P and Harrison, W and Markowitz, J and Rabkin, J and Tricamo, E and Goetz, D and Klein, D. (1988) Antidepressant specificity in atypical depression Arch Gen Psychiatry, 45, pp. 129-137.
63. Loosen, P. (1985) The TRH-induced TSH response in psychiatric patients: A possible neuroendocrine marker Psychoneuroendocrinology, 10, pp. 237-260.
64. Lucas, A and Pizarro, E and Granada, M and Salinas, I and Sanmarti, A. (2001) Postpartum thyroid dysfunction and postpartum depression: Are they two linked disorders? Clin Endocrinol, 55, pp. 809-814.
65. Maes, M and Meltzer, H and Cosyns, P and Suy, E and Schotte, C. (1993) An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: Results of a large-scaled and controlled study Psychoneuroendocrinology, 18, pp. 607-620.
66. Maes, M and D'Hondt, P and Blockx, P and Cosyns, P. (1994a) A further investigation of basal HPT axis function in unipolar depression: Effects of diagnosis, hospitalization, and dexamethasone administration Psychiatry Res, 51, pp. 185-201.
67. Maes, M and Scharp?, S and Cosyns, P and Meltzer, H. (1994b) Relationships between basal hypothalamic-pituitary-thyroid-axis activity and plasma haptoglobin levels in depression J Psychiatr Res, 28, pp. 123-134.
68. MarangellLB. 2000. Augmentation of standard depression therapy. Clin Ther 22(Suppl A):A25-38; Discussion A39-41.
69. Marchesi, C and Chiodera, P and DeRisio, C and Dassζ, L and Govi, A and DeFerri, A and Piagneri, B and Minelli, R and Bianconi, L and Gnudi, A. (1988) Dopaminergic control of TSH secretion in endogenous depression Psychiatry Res, 25, pp. 277-282.
70. Mendlewicz, J and Hubain, P and Koumakis, C. (1984) Further investigation of the dexamethasone suppression test in affective illness: Relationship to clinical diagnosis and therapeutic response Neuropsychobiology, 12, pp. 23-26.
71. MusselmanDL, NemeroffCB. 1996. Depression and endocrine disorders: Focus on the thyroid and adrenal system. Br J Psychiatry Suppl 123-128.
72. Nelson, C and Davis, J. (1997) DST studies in psychotic depression: A meta-analysis Am J Psychiatry, 154, pp. 1497-1503.
73. Nemeroff, C. (1989) Clinical significance of psychoneuroendocrinology in psychiatry: Focus on the thyroid and adrenal J Clin Psychiatry, 50(Suppl), pp. 13-20.
74. Nemeroff, C and Simon, J and Haggerty, J and Evans, D. (1985) Antithyroid antibodies in depressed patients Am J Psychiatry, 142, pp. 840-843.
75. Nemeroff, CB. (1996) Augmentation strategies in patients with refractory depression Depress Anxiety, 4, pp. 169-181.
76. O'Donnell, M and Silove, D and Wakefield, D. (1988) Current perspectives on immunology and psychiatry Aust NZ J Psychiatry, 22, pp. 366-382.
77. Ordas, DM and Labbate, LA. (1995) Routine screening of thyroid function in patients hospitalized for major depression or dysthymia? Ann Clin Psychiatry, 7, pp. 161-165.
78. Orth, D and Shelton, R and Nicholson, W and Beck-Peccoz, P and Tomarken, A and Persani, L and Loosen, P. (2001) Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression Arch Gen Psychiatry, 58, pp. 77-83.
79. Overall, J and Hollister, L and Johnson, M. (1966) Nosology of depression and differential response to drugs J Am Med Assoc, 195, pp. 946-950.
80. Pedersen, C. (1999) Postpartum mood and anxiety disorders: A guide for the nonpsychiatric clinician with an aside on thyroid associations with postpartum mood Thyroid, 9, pp. 691-697.
81. Pop, V and Maartens, L and Leusink, G and vanSon, M and Knottnerus, A and Ward, A and Metcalfe, R and Weetman, A. (1998) Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab, 83, pp. 3194-3197.
82. Post, RM and Leverich, GS and Denicoff, KD and Frye, MA and Kimbrell, TA and Dunn, R. (1997) Alternative approaches to refractory depression in bipolar illness Depress Anxiety, 5, pp. 175-89.
83. Pridmore, S and Turnier-Shea, Y. (2004) Medication options in the treatment of treatment-resistant depression Aust NZ J Psychiatry, 38, pp. 219-225.
84. Rao, M and Vartzopoulos, D and Fels, K. (1989) Thyroid function in anxious and depressed patients Pharmacopsychiatry, 22, pp. 66-70.
85. Rao, M and Ruhrmann, S and Retey, B and Liappis, N and Fuger, J and Kraemer, M and Kasper, S and Møller, H. (1996) Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome Pharmacopsychiatry, 29, pp. 180-186.
86. Reed, L and Pangaro, L.(1995) Physiology of the thyroid gland I: Synthesis and release, iodine metabolism and binding and transport. In Principles and practice of endocrinology and metabolism. (pp. 285-291). Philadelphia PA: JB Lippincott Company.
87. Roth, M. (1959) The phenomenology of depressive states Can Psychiatr Assoc J, 4(Suppl), pp. 32-52.
88. Rupprecht, R and Rupprecht, C and Rupprecht, M and Noder, M and Mahlstedt, J. (1989) Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls Biol Psychiatry, 25, pp. 22-32.
89. Sagud, M and Pivac, N and Muck-Seler, D and Jakovljevic, M and Mihaljevic-Peles, A and Korsic, M. (2002) Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients Neuropsychobiology, 45, pp. 139-43.
90. Sargant, W. (1960) Some newer drugs in the treatment of depression and their relation to other somatic treatments Psychosomatics, 1, pp. 14-17.
91. Schindler, BA. (1985) Stress, affective disorders, and immune function Med Clin North Am, 69, pp. 585-597.
92. Schule C, Baghai T. C, Alajbegovic L, Schwarz M, Zwanzger P, Eser D, Schaaf L, Moller H. J, Rupprecht R. 2005. The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients. Eur Arch Psychiatry Clin Neurosci in press.
93. SheltonRC. 1999. Treatment options for refractory depression. J Clin Psychiatry 60(Suppl 4):57-61; Discussion 62-63.
94. Sher, L and Rosenthal, N and Wehr, T. (1999) Free thyroxine and thyroid-stimulating hormone levels in patients with seasonal affective disorder and matched controls J Affect Disord, 56, pp. 195-199.
95. Staner, L and De La Fuente, JM and Kerkhofs, M and Linkowski, P and Mendlewicz, J. (1992) Biological and clinical features of recurrent brief depression: A comparison with major depressed and healthy subjects J Affect Disord, 26, pp. 241-245.
96. Stein, M and Uhde, T. (1989) Autoimmune thyroiditis and panic disorder Am J Psychiatry, 146, pp. 259-260.
97. Sullivan, G and Hatterer, J and Herbert, J. (1999) Low levels of transthyretin in the CSF of depressed patients Am J Psychiatry, 156, pp. 710-715.
98. SussmanN, JoffeRT. 1998. Introduction: Augmentation of antidepressant medication. J Clin Psychiatry 59(Suppl 5):3-4; Discussion 70-73.
99. Szuba, M and O'Reardon, J and Rai, A and Snyder-Kastenberg, J and Amsterdam, J and Gettes, D and Wassermann, E and Evans, D. (2001) Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression Biol Psychiatry, 50, pp. 22-27.
100. ThaseME, HowlandRH, FriedmanES. 1998. Treating antidepressant nonresponders with augmentation strategies: An overview J Clin Psychiatry 59(Suppl 5):5-12; Discussion 13-15.
101. Van Praag, H and Uleman, A and Spitz, J. (1965) The vital syndrome interview Psychiatr Neurol Neurochir, 68, pp. 329-349.
102. vanWest, D and Maes, M. (1999) Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression Neuroendocrinol Lett, 20, pp. 11-17.